Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies
Open Access
- 15 May 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (10) , 1454-1463
- https://doi.org/10.1086/383031
Abstract
Anemia in human immunodeficiency virus (HIV)–infected patients can have serious implications, which vary from functional and quality-of-life decremenKeywords
This publication has 37 references indexed in Scilit:
- Iron‐Deficiency Anemia and the Cycle of Poverty among Human Immunodeficiency Virus–Infected Women in the Inner CityClinical Infectious Diseases, 2003
- Prevalence and Cumulative Incidence of and Risk Factors for Anemia in a Multicenter Cohort Study of Human Immunodeficiency Virus–Infected and –Uninfected WomenClinical Infectious Diseases, 2002
- A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA StudyThe Journal of Infectious Diseases, 2002
- Highly Active Antiretroviral Therapy Associated with Improved Anemia Among HIV-Infected WomenAIDS Patient Care and STDs, 2001
- Consensus statement: Anemia in HIV infection—current trends, treatment options, and practice strategiesClinical Therapeutics, 2000
- Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell LinesJournal of Biological Chemistry, 1999
- B7-1 (CD80)-gene transfer combined with interleukin-12 administration elicits protective and therapeutic immunity against mouse hepatocellular carcinomaHepatology, 1999
- Thrombotic thrombocytopenic purpura in patients with human immunodeficiency virus infection: A report of three cases and review of the literatureAmerican Journal of Hematology, 1992
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987